Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

197.00
+0.52000.26%
Post-market: 196.03-0.9699-0.49%17:58 EDT
Volume:37.39M
Turnover:7.35B
Market Cap:78.65B
PE:-24.60
High:199.92
Open:196.42
Low:192.71
Close:196.48
52wk High:212.22
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:2.38
T/O Rate:10.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:11.63
PE(LYR):-27.13

Loading ...

Early notable gainers among liquid option names on August 25th

TIPRANKS
·
Aug 25

Moderna Shares up 8.4% as Barclays Hikes Price Target

THOMSON REUTERS
·
Aug 25

Movement Alert|Moderna, Inc. Rises 4.3% in Regular Trading, Continued Price Reassessment After Cancer Vaccine Phase III Success

Market Focus
·
Aug 25

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday as Chip Stocks Recover

MT Newswires Live
·
Aug 25

After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)

TIPRANKS
·
Aug 25

Moderna upgraded to Peer Perform from Underperform at Wolfe Research

TIPRANKS
·
Aug 25

Movement Alert|Moderna, Inc. Rises 3.99% in Pre-Market Trading, Continues Volatile Re-Rating After mRNA Cancer Vaccine Phase III Success

Market Focus
·
Aug 25

Binance launches 5 stock perpetuals with 20x leverage

cryptonews
·
Aug 25

Moderna's Landmark mRNA Cancer Vaccine Trial Success Ignites Biotech Sector Rally, Valuation Reset May Be Just Beginning

Stock News
·
Aug 25

Moderna Inc. Stock Slides 4.3%, Underperforms Peers

Dow Jones
·
Aug 25

Moderna (MRNA) Stock Looks Above Fair Value On Sales But Strong On Returns

Simply Wall St.
·
Aug 25

Moderna Inc Stock (MRNA) Moved Down by 5.13% on Aug 24: A Full Analysis

TradingKey
·
Aug 25

Moderna is Betting Big on Its Cancer Vaccine. This is What Wall Street Wants to See.

Dow Jones
·
Aug 24

Movement Alert|Moderna, Inc. Falls 5.65% in Regular Trading, Continued Repricing Volatility After mRNA Cancer Vaccine Phase III Breakthrough

Market Focus
·
Aug 24

U.S. Stocks on the MOVE-Jersey Mike's Sub, Moderna, PDD Holding

Reuters
·
Aug 24

Barclays Raises Moderna PT on 'transformative' Melanoma Vaccine Potential

Reuters
·
Aug 24

Barclays Adjusts Price Target on Moderna to $125 From $48

MT Newswires Live
·
Aug 24

Moderna price target raised to $125 from $48 at Barclays

TIPRANKS
·
Aug 24

BUZZ-US Stocks Weekly: Rate Rattle

Reuters
·
Aug 24

Option Movers | Tesla Surges 5%, yet Institutions Are Bearish; Coinbase Climbs over 8%, and Investors Remain Cautious

Option Movers
·
Aug 24